Anixa Biosciences Faces Financial Scrutiny Amid Stock Volatility and Negative Earnings
Anixa Biosciences, a biotech company focused on cancer diagnostics and therapeutics, has experienced significant stock fluctuations and financial metrics that warrant further analysis.
2 minutes to read